CKD group (encompassing patients categorized as being of moderate, high, or very high CKD risk)
In March, the US Food and Drug Administration approved the drug as a treatment to reduce the risk of heart attack and stroke in obese or overweight adults with cardiovascular disease
Compounded tirzepatide is a custom-made version of the active pharmaceutical ingredient tirzepatide, prepared by a compounding pharmacy
What to Expect: GLP-1 Treatment Timeline Week 1-4: Your body adjusts to the medication
Similarly, people with a history of psychiatric medications were 12% more likely to discontinue treatment within the first year, while those living with cardiovascular disease or other chronic conditions were around 10% more likely to stop treatment early, also suggesting a higher likelihood of experiencing adverse effects
If reconstituted with 5mL of sterile water , the following dosing conversions apply: 25mg = 0.25mL (25 units) 50mg = 0.50mL (50 units) 100mg = 1.00mL (100 units) Missed Dose: If a dose is missed, administer as soon as possible unless it is close to the time of the next scheduled dose